Differing effects on gall-bladder motility of lanreotide SR and octreotide LAR for treatment of acromegaly.

Eitemau Tebyg

• A comparison of lanreotide and octreotide LAR for treatment of acromegaly.
  gan: Turner, H, et al.
  Cyhoeddwyd: (1999)
• Systematic dose-extension of octreotide LAR: the importance of individual tailoring of treatment in patients with acromegaly.
  gan: Turner, H, et al.
  Cyhoeddwyd: (2004)
• Replacement of prolonged-acting octreotide with lanreotide autogel 120 mg in patients with Acromegaly in real clinical practice
  gan: U. A. Tsoy, et al.
  Cyhoeddwyd: (2022-06-01)
• Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide.
  gan: Karavitaki, N, et al.
  Cyhoeddwyd: (2008)
• Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
  gan: Ramírez, C, et al.
  Cyhoeddwyd: (2012)